Anshan Hifichem Future Growth
Future criteria checks 5/6
Anshan Hifichem is forecast to grow earnings and revenue by 41% and 27.1% per annum respectively. EPS is expected to grow by 39.2% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
41.0%
Earnings growth rate
39.2%
EPS growth rate
| Chemicals earnings growth | 33.9% |
| Revenue growth rate | 27.1% |
| Future return on equity | 12.9% |
| Analyst coverage | Low |
| Last updated | 20 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,694 | 313 | N/A | 330 | 1 |
| 12/31/2025 | 2,204 | 250 | N/A | 157 | 1 |
| 12/31/2024 | 1,601 | 175 | N/A | 222 | 1 |
| 6/30/2024 | 1,385 | 90 | -36 | 86 | N/A |
| 3/31/2024 | 1,277 | 47 | -93 | 48 | N/A |
| 12/31/2023 | 1,218 | 11 | -164 | 2 | N/A |
| 9/30/2023 | 1,168 | -30 | -172 | 43 | N/A |
| 6/30/2023 | 1,147 | -40 | -163 | 56 | N/A |
| 3/31/2023 | 1,149 | -42 | -80 | 122 | N/A |
| 1/1/2023 | 1,209 | -3 | -99 | 92 | N/A |
| 9/30/2022 | 1,343 | 53 | -40 | 107 | N/A |
| 6/30/2022 | 1,370 | 93 | -38 | 118 | N/A |
| 3/31/2022 | 1,361 | 157 | -63 | 107 | N/A |
| 1/1/2022 | 1,347 | 180 | -1 | 161 | N/A |
| 9/30/2021 | 1,248 | 192 | -25 | 143 | N/A |
| 6/30/2021 | 1,193 | 197 | -39 | 119 | N/A |
| 3/31/2021 | 1,142 | 187 | -26 | 123 | N/A |
| 12/31/2020 | 1,008 | 175 | -141 | 93 | N/A |
| 9/30/2020 | 877 | 141 | -181 | 84 | N/A |
| 6/30/2020 | 774 | 142 | -195 | 62 | N/A |
| 3/31/2020 | 724 | 130 | -238 | 15 | N/A |
| 12/31/2019 | 695 | 108 | -99 | 49 | N/A |
| 9/30/2019 | 661 | 120 | -56 | 47 | N/A |
| 6/30/2019 | 664 | 111 | -8 | 85 | N/A |
| 3/31/2019 | 628 | 100 | -3 | 87 | N/A |
| 12/31/2018 | 611 | 105 | -23 | 68 | N/A |
| 9/30/2018 | 606 | 115 | -7 | 63 | N/A |
| 6/30/2018 | 583 | 110 | 29 | 76 | N/A |
| 3/31/2018 | 550 | 101 | N/A | 48 | N/A |
| 12/31/2017 | 553 | 103 | N/A | 72 | N/A |
| 9/30/2017 | 525 | 100 | N/A | 61 | N/A |
| 6/30/2017 | 498 | 96 | N/A | 51 | N/A |
| 3/31/2017 | 470 | 86 | N/A | 62 | N/A |
| 12/31/2016 | 442 | 76 | N/A | 73 | N/A |
| 9/30/2016 | 419 | 60 | N/A | N/A | N/A |
| 6/30/2016 | 396 | 44 | N/A | 29 | N/A |
| 3/31/2016 | 383 | 41 | N/A | 30 | N/A |
| 12/31/2015 | 370 | 39 | N/A | 32 | N/A |
| 12/31/2014 | 323 | 18 | N/A | 38 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300758's forecast earnings growth (41% per year) is above the savings rate (2.9%).
Earnings vs Market: 300758's earnings (41% per year) are forecast to grow faster than the CN market (23.3% per year).
High Growth Earnings: 300758's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300758's revenue (27.1% per year) is forecast to grow faster than the CN market (13.2% per year).
High Growth Revenue: 300758's revenue (27.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300758's Return on Equity is forecast to be low in 3 years time (12.9%).